284 related articles for article (PubMed ID: 17939909)
1. [Trends in prognostic factors for neuroendocrine lung tumors].
García-Yuste M; Molins L; Matilla JM; González-Aragoneses F; López-Pujol J; Ramos G; de la Torre M;
Arch Bronconeumol; 2007 Oct; 43(10):549-56. PubMed ID: 17939909
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in neuroendocrine lung tumors: a Spanish Multicenter Study. Spanish Multicenter Study of Neuroendocrine Tumors of the Lung of the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR).
García-Yuste M; Matilla JM; Alvarez-Gago T; Duque JL; Heras F; Cerezal LJ; Ramos G
Ann Thorac Surg; 2000 Jul; 70(1):258-63. PubMed ID: 10921719
[TBL] [Abstract][Full Text] [Related]
3. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
Langfort R; Rudziński P; Burakowska B
Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
[TBL] [Abstract][Full Text] [Related]
4. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
5. Typical and atypical pulmonary carcinoids : outcome in patients presenting with regional lymph node involvement.
Thomas CF; Tazelaar HD; Jett JR
Chest; 2001 Apr; 119(4):1143-50. PubMed ID: 11296182
[TBL] [Abstract][Full Text] [Related]
6. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].
Correia Sda S; Pinto C; Bernardo J
Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291
[TBL] [Abstract][Full Text] [Related]
7. Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung.
García-Yuste M; Matilla JM; Cueto A; Paniagua JM; Ramos G; Cañizares MA; Muguruza I;
Eur J Cardiothorac Surg; 2007 Feb; 31(2):192-7. PubMed ID: 17196822
[TBL] [Abstract][Full Text] [Related]
8. [Neuroendocrine tumors of the lung].
Oliaro A; Donati G; Filosso PL; Ruffini E
Minerva Chir; 2000; 55(1-2):7-16. PubMed ID: 10832278
[TBL] [Abstract][Full Text] [Related]
9. Reclassification of neuroendocrine tumors improves the separation of carcinoids and the prediction of survival.
Skov BG; Krasnik M; Lantuejoul S; Skov T; Brambilla E
J Thorac Oncol; 2008 Dec; 3(12):1410-5. PubMed ID: 19057265
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in neuroendocrine tumours of the lung: a single-centre experience.
Filosso PL; Ruffini E; Di Gangi S; Guerrera F; Bora G; Ciccone G; Galassi C; Solidoro P; Lyberis P; Oliaro A; Sandri A
Eur J Cardiothorac Surg; 2014 Mar; 45(3):521-6; discussion 526. PubMed ID: 24092506
[TBL] [Abstract][Full Text] [Related]
11. Improvement in TNM staging of pulmonary neuroendocrine tumors requires histology and regrouping of tumor size.
Cattoni M; Vallières E; Brown LM; Sarkeshik AA; Margaritora S; Siciliani A; Filosso PL; Guerrera F; Imperatori A; Rotolo N; Farjah F; Wandell G; Costas K; Mann C; Hubka M; Kaplan S; Farivar AS; Aye RW; Louie BE
J Thorac Cardiovasc Surg; 2018 Jan; 155(1):405-413. PubMed ID: 28986041
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine Tumors of the Lung: Updates and Diagnostic Pitfalls.
Hung YP
Surg Pathol Clin; 2019 Dec; 12(4):1055-1071. PubMed ID: 31672294
[TBL] [Abstract][Full Text] [Related]
13. Staging System for Neuroendocrine Tumors of the Lung Needs to Incorporate Histologic Grade.
Jackson AS; Rosenthal A; Cattoni M; Bograd AJ; Farivar AS; Aye RW; Vallières E; Louie BE
Ann Thorac Surg; 2020 Apr; 109(4):1009-1018. PubMed ID: 31706866
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors.
Galván JA; Astudillo A; Vallina A; Crespo G; Folgueras MV; González MV
BMC Cancer; 2014 Nov; 14():855. PubMed ID: 25413006
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine neoplasms of the lung: a prognostic spectrum.
Asamura H; Kameya T; Matsuno Y; Noguchi M; Tada H; Ishikawa Y; Yokose T; Jiang SX; Inoue T; Nakagawa K; Tajima K; Nagai K
J Clin Oncol; 2006 Jan; 24(1):70-6. PubMed ID: 16382115
[TBL] [Abstract][Full Text] [Related]
16. The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer.
Travis WD; Giroux DJ; Chansky K; Crowley J; Asamura H; Brambilla E; Jett J; Kennedy C; Rami-Porta R; Rusch VW; Goldstraw P;
J Thorac Oncol; 2008 Nov; 3(11):1213-23. PubMed ID: 18978555
[TBL] [Abstract][Full Text] [Related]
17. Distribution and Characteristics of Pulmonary Neuroendocrine Tumors: Single Institution Experience in Lebanon.
Kesrouani C; Ghorra C; Rassy M; Kourie HR; Kattan J
Asian Pac J Cancer Prev; 2016; 17(5):2579-81. PubMed ID: 27268633
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary large cell carcinomas with neuroendocrine features are high-grade neuroendocrine tumors.
Iyoda A; Hiroshima K; Baba M; Saitoh Y; Ohwada H; Fujisawa T
Ann Thorac Surg; 2002 Apr; 73(4):1049-54. PubMed ID: 11996239
[TBL] [Abstract][Full Text] [Related]
19. ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival.
Skov BG; Holm B; Erreboe A; Skov T; Mellemgaard A
J Thorac Oncol; 2010 Apr; 5(4):453-9. PubMed ID: 20104194
[TBL] [Abstract][Full Text] [Related]
20. Molecular markers help characterize neuroendocrine lung tumors.
Rusch VW; Klimstra DS; Venkatraman ES
Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]